Crosspoint Capital Strategies’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-170	Closed	-$11K	–	840
2015 Q2	$11K	Buy	+170	New	+$11K	﹤0.01%	486
2014 Q2	–	Sell	-200	Closed	-$8K	–	578
2014 Q1	$8K	Buy	+200	New	+$8K	﹤0.01%	500